{"hands_on_practices": [{"introduction": "Before we can study the function of DNA methylation, we must first be able to detect it. This practice introduces a classic and elegant experimental method using methylation-sensitive restriction enzymes. By comparing the digestion patterns of two enzymes that recognize the same DNA sequence but differ in their sensitivity to methylation, you can deduce the epigenetic state of a specific locus [@problem_id:1482939]. This exercise hones data interpretation skills that are fundamental to molecular genetics.", "problem": "In molecular biology, DNA methylation is a crucial epigenetic modification that often occurs at CpG dinucleotides (a cytosine nucleotide followed by a guanine nucleotide). This modification can alter gene expression without changing the underlying DNA sequence. To investigate the methylation status of a specific gene, researchers often use a pair of restriction enzymes called isoschizomers, which recognize the same DNA sequence but have different sensitivities to methylation.\n\nConsider the isoschizomers HpaII and MspI, both of which recognize the sequence 5'-CCGG-3'. HpaII is methylation-sensitive and will not cut the DNA if the internal cytosine of the recognition sequence is methylated. In contrast, MspI is methylation-insensitive and will cut the sequence regardless of the methylation status of that same cytosine.\n\nA geneticist is studying a specific 1000 base pair (bp) linear DNA fragment isolated from two different sources: Tissue A and Tissue B. This fragment is known to contain exactly one 5'-CCGG-3' recognition site, located 300 bp from one of the ends. For each tissue source, the purified DNA is divided into three samples.\n- Sample 1: No enzyme is added (Control).\n- Sample 2: The DNA is digested with the enzyme HpaII.\n- Sample 3: The DNA is digested with the enzyme MspI.\n\nAll samples are then analyzed using agarose gel electrophoresis, a technique that separates DNA fragments by size. The results are as follows:\n\n**Results for Tissue A:**\n- Control sample: Shows a single DNA band at 1000 bp.\n- HpaII-digested sample: Shows a single DNA band at 1000 bp.\n- MspI-digested sample: Shows two DNA bands, one at 700 bp and one at 300 bp.\n\n**Results for Tissue B:**\n- Control sample: Shows a single DNA band at 1000 bp.\n- HpaII-digested sample: Shows two DNA bands, one at 700 bp and one at 300 bp.\n- MspI-digested sample: Shows two DNA bands, one at 700 bp and one at 300 bp.\n\nBased on these experimental outcomes, determine the methylation status of the CCGG site in the DNA from Tissue A and Tissue B.\n\nA. The site is methylated in Tissue A and methylated in Tissue B.\n\nB. The site is unmethylated in Tissue A and unmethylated in Tissue B.\n\nC. The site is methylated in Tissue A and unmethylated in Tissue B.\n\nD. The site is unmethylated in Tissue A and methylated in Tissue B.\n\nE. The experiment is inconclusive because the enzymes did not function as expected.\n\nF. The site is partially methylated in both tissues.", "solution": "The problem requires us to interpret the results of a restriction enzyme digest experiment to determine the DNA methylation status at a specific site in two different tissues.\n\nFirst, let's establish the principles of the assay and the expected outcomes under different conditions.\nThe DNA fragment is linear and 1000 base pairs (bp) long. It contains a single 5'-CCGG-3' recognition site located 300 bp from one end.\nIf an enzyme successfully cuts the DNA at this site, it will cleave the 1000 bp fragment into two smaller fragments: one of length 300 bp and another of length $1000 - 300 = 700$ bp.\nIf an enzyme fails to cut the DNA, the fragment will remain intact at its original length of 1000 bp.\n\nThe key to the experiment lies in the differential sensitivity of the enzymes HpaII and MspI to methylation at the internal cytosine of the CCGG site.\n- MspI is methylation-insensitive. It will always cut the CCGG site if it is present. Therefore, the MspI digest acts as a positive control, confirming the presence of the site and the enzyme's activity.\n- HpaII is methylation-sensitive. It will only cut the CCGG site if the internal cytosine is *unmethylated*. It will not cut if the site is methylated.\n\nNow, let's analyze the results for each tissue.\n\n**Analysis of Tissue A:**\n- The control sample shows a 1000 bp band. This is expected and confirms the starting size of the DNA fragment.\n- The MspI-digested sample shows two bands at 700 bp and 300 bp. This indicates that MspI successfully cut the DNA. This result confirms that the CCGG site is indeed present at the expected location and that the general conditions for enzyme digestion were met.\n- The HpaII-digested sample shows a single band at 1000 bp. This means that HpaII failed to cut the DNA. Since we know from the MspI result that the site is present and accessible, the only possible reason for HpaII's failure to cut is that the internal cytosine of the CCGG site is methylated.\n- Conclusion for Tissue A: The CCGG site is methylated.\n\n**Analysis of Tissue B:**\n- The control sample shows a 1000 bp band, which is the expected result.\n- The MspI-digested sample shows two bands at 700 bp and 300 bp. As with Tissue A, this confirms the presence of the CCGG site and the activity of the MspI enzyme.\n- The HpaII-digested sample also shows two bands at 700 bp and 300 bp. This result indicates that HpaII successfully cut the DNA at the CCGG site.\n- Conclusion for Tissue B: For HpaII to be able to cut the site, the site must be unmethylated.\n\n**Final Conclusion:**\nBy combining the analysis of both tissues, we conclude that the CCGG site is methylated in the DNA from Tissue A and unmethylated in the DNA from Tissue B. This corresponds to option C in the multiple-choice list.", "answer": "$$\\boxed{C}$$", "id": "1482939"}, {"introduction": "While restriction enzymes are excellent for specific sites, modern epigenetics often requires a more comprehensive view. This practice delves into the chemical principles behind bisulfite sequencing, the gold standard for high-resolution methylation analysis. You will model the effect of sodium bisulfite treatment, which converts unmethylated cytosines to uracil, and calculate the consequences for the DNA sequence after amplification [@problem_id:1482959]. This quantitative problem reinforces the molecular basis of a technique that has revolutionized our ability to map epigenomes.", "problem": "A molecular biologist is studying the epigenetics of a novel virus which has a genome composed of a single-stranded DNA (ssDNA) molecule. The ssDNA genome is known to be 8000 bases long. An analysis of the untreated genome reveals its base composition to be 20% adenine (A), 25% cytosine (C), 30% guanine (G), and 25% thymine (T).\n\nTo investigate DNA methylation, the biologist treats the viral ssDNA with sodium bisulfite. This chemical treatment converts all unmethylated cytosine residues to uracil (U), but does not affect methylated cytosines, adenines, guanines, or thymines. In this specific viral genome, exactly 40% of the cytosine residues are methylated.\n\nAfter the bisulfite treatment, the modified ssDNA molecule is used as a template in a Polymerase Chain Reaction (PCR) to generate a large quantity of double-stranded DNA product. During PCR, DNA polymerase reads uracil (U) as if it were thymine (T).\n\nCalculate the expected Guanine-Cytosine (G+C) content of the final population of double-stranded DNA molecules produced by the PCR. Express your answer as a decimal rounded to three significant figures.", "solution": "Let the genome length be $L=8000$ bases with initial single-strand composition\n$$f_{A}=0.20,\\quad f_{C}=0.25,\\quad f_{G}=0.30,\\quad f_{T}=0.25.$$\nA fraction $m=0.40$ of cytosines are methylated. Upon bisulfite treatment, unmethylated cytosines ($1-m$ fraction of $f_{C}$) convert to uracil and are read as thymine during PCR, while methylated cytosines remain as cytosine.\n\nTherefore, in the PCR-amplified strand corresponding to the original orientation,\n$$f_{C}^{\\prime}=f_{C}m,$$\n$$f_{T}^{\\prime}=f_{T}+f_{C}(1-m),$$\n$$f_{A}^{\\prime}=f_{A},\\quad f_{G}^{\\prime}=f_{G}.$$\n\nThe G+C content of the final double-stranded DNA equals the fraction of positions that are G or C on one strand (each such position corresponds to a G-C base pair in the duplex):\n$$\\text{GC content}=f_{G}^{\\prime}+f_{C}^{\\prime}=f_{G}+f_{C}m.$$\n\nSubstituting the given values,\n$$\\text{GC content}=0.30+0.25\\times 0.40=0.30+0.10=0.40.$$\n\nRounded to three significant figures, this is $0.400$.", "answer": "$$\\boxed{0.400}$$", "id": "1482959"}, {"introduction": "Understanding methylation patterns is one thing; understanding their consequences for gene regulation is another. This final practice challenges you to apply your knowledge to a complex biological system involving genomic imprinting and targeted epigenetic editing. By predicting how the artificial demethylation of an Imprinted Control Region (ICR) using dCas9-TET1 technology alters gene expression, you will synthesize concepts of enhancers, insulators, and parent-of-origin effects [@problem_id:1482955]. This problem showcases how understanding fundamental mechanisms allows us to predict the outcomes of cutting-edge genetic engineering.", "problem": "In a hypothetical diploid mammalian species, a critical imprinted locus on an autosome contains two genes, `Gene-ALPHA` and `Gene-BETA`, which are essential for embryonic development. Their expression is regulated by an adjacent DNA element known as an Imprinted Control Region (ICR). The regulatory logic of this locus, which includes a distal enhancer and a specific Insulator Protein (IP), is as follows:\n\n1.  On the paternally inherited chromosome, the ICR is hypermethylated. This methylation prevents the IP from binding to the ICR. Consequently, the distal enhancer is able to interact with and strongly activate the promoter of `Gene-ALPHA`. The promoter of `Gene-BETA`, which is part of the methylated ICR, is silenced.\n2.  On the maternally inherited chromosome, the ICR is unmethylated. The IP binds to this unmethylated ICR, creating an insulator boundary that physically blocks the distal enhancer from accessing the `Gene-ALPHA` promoter, thus silencing it. However, the unmethylated ICR itself functions as an active promoter for `Gene-BETA`.\n\nIn wild-type diploid cells, the total cellular expression level from both alleles for `Gene-ALPHA` is denoted as `E_A`, and for `Gene-BETA` is `E_B`. Both `E_A` and `E_B` are non-zero.\n\nA team of genetic engineers performs an experiment on a culture of these wild-type cells. They introduce a custom-designed fusion protein, dCas9-TET1. Here, dCas9 refers to nuclease-dead Cas9, which can bind to a specific DNA sequence guided by an RNA molecule but cannot cleave the DNA. TET1 (Ten-eleven translocation 1) is an enzyme that initiates the process of active DNA demethylation. A guide RNA is co-expressed that specifically targets the dCas9-TET1 protein exclusively to the ICR on the paternally inherited chromosome. The experiment is successful, and the targeted paternal ICR is completely demethylated in all treated cells.\n\nAssuming the expression level from a single active allele is consistent, what are the new total cellular expression levels for `Gene-ALPHA` and `Gene-BETA` in the treated cells, expressed as a pair of ratios relative to their normal wild-type levels (New `Gene-ALPHA` Level / `E_A`, New `Gene-BETA` Level / `E_B`)?\n\nA. (1, 1)\n\nB. (2, 0)\n\nC. (0, 2)\n\nD. (0.5, 1)\n\nE. (1, 0.5)", "solution": "The user wants me to determine the expression levels of `Gene-ALPHA` and `Gene-BETA` after an experimental manipulation and express them as ratios relative to the wild-type levels.\n\nFirst, let's establish the baseline expression in a normal, wild-type diploid cell. Let the transcriptional output from a single active `Gene-ALPHA` allele be `x` and from a single active `Gene-BETA` allele be `y`.\n\n- **Maternal Allele (Wild-Type):** The Imprinted Control Region (ICR) is unmethylated. The Insulator Protein (IP) binds. This blocks the enhancer, so `Gene-ALPHA` is OFF. The unmethylated ICR acts as a promoter for `Gene-BETA`, so `Gene-BETA` is ON.\n  - Contribution to total expression: `Gene-ALPHA` = 0, `Gene-BETA` = `y`.\n\n- **Paternal Allele (Wild-Type):** The ICR is methylated. The IP cannot bind. The enhancer activates `Gene-ALPHA`, so `Gene-ALPHA` is ON. The methylated ICR silences `Gene-BETA`, so `Gene-BETA` is OFF.\n  - Contribution to total expression: `Gene-ALPHA` = `x`, `Gene-BETA` = 0.\n\n- **Total Wild-Type Expression (`E_A`, `E_B`):** We sum the contributions from both alleles.\n  - Total `Gene-ALPHA` expression, `E_A` = (Maternal contribution) + (Paternal contribution) = 0 + `x` = `x`.\n  - Total `Gene-BETA` expression, `E_B` = (Maternal contribution) + (Paternal contribution) = `y` + 0 = `y`.\n\nNext, let's analyze the state of the cell after the experimental treatment. The dCas9-TET1 fusion protein, guided by a specific RNA, demethylates the ICR on the paternal chromosome. The maternal chromosome is unaffected.\n\n- **Maternal Allele (Treated Cell):** Unchanged. The ICR remains unmethylated. `Gene-ALPHA` is OFF, and `Gene-BETA` is ON.\n  - Contribution to total expression: `Gene-ALPHA` = 0, `Gene-BETA` = `y`.\n\n- **Paternal Allele (Treated Cell):** The ICR has been demethylated by TET1. This makes its state identical to that of a normal maternal ICR.\n  - Since the paternal ICR is now unmethylated, the Insulator Protein (IP) will bind to it.\n  - The bound IP will create an insulator, blocking the enhancer from activating `Gene-ALPHA`. Therefore, `Gene-ALPHA` on the paternal allele is now OFF.\n  - The now-unmethylated paternal ICR will function as a promoter for `Gene-BETA`. Therefore, `Gene-BETA` on the paternal allele is now ON.\n  - Contribution to total expression: `Gene-ALPHA` = 0, `Gene-BETA` = `y`.\n\nNow, we calculate the new total cellular expression levels in the treated cells by summing the contributions from the (unchanged) maternal allele and the (modified) paternal allele.\n\n- **New Total `Gene-ALPHA` Expression:** (Maternal contribution) + (Treated Paternal contribution) = 0 + 0 = 0.\n- **New Total `Gene-BETA` Expression:** (Maternal contribution) + (Treated Paternal contribution) = `y` + `y` = `2y`.\n\nFinally, we need to express these new levels as ratios relative to the original wild-type levels, `E_A` and `E_B`.\nRecall that `E_A = x` and `E_B = y`.\n\n- **Ratio for `Gene-ALPHA`:** (New `Gene-ALPHA` Level) / `E_A` = `0 / x` = 0.\n- **Ratio for `Gene-BETA`:** (New `Gene-BETA` Level) / `E_B` = `2y / y` = 2.\n\nThe resulting pair of ratios is (0, 2). This corresponds to option C.", "answer": "$$\\boxed{C}$$", "id": "1482955"}]}